Cubist Systematic Strategies’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.5M Buy
645,183
+393,565
+156% +$7.01M 0.05% 243
2025
Q1
$4.48M Sell
251,618
-83,600
-25% -$1.49M 0.03% 461
2024
Q4
$9.99M Buy
335,218
+231,466
+223% +$6.9M 0.06% 179
2024
Q3
$1.62M Sell
103,752
-250,281
-71% -$3.91M 0.01% 681
2024
Q2
$6.06M Sell
354,033
-559,768
-61% -$9.59M 0.04% 266
2024
Q1
$14.3M Buy
913,801
+296,433
+48% +$4.63M 0.08% 146
2023
Q4
$9.22M Sell
617,368
-182,987
-23% -$2.73M 0.06% 256
2023
Q3
$12.9M Buy
800,355
+785,498
+5,287% +$12.7M 0.1% 171
2023
Q2
$617K Sell
14,857
-74,398
-83% -$3.09M ﹤0.01% 1333
2023
Q1
$5.37M Buy
+89,255
New +$5.37M 0.03% 560
2022
Q4
Sell
-71,463
Closed -$5.43M 3489
2022
Q3
$5.43M Buy
71,463
+11,218
+19% +$852K 0.03% 768
2022
Q2
$4.19M Sell
60,245
-17,074
-22% -$1.19M 0.03% 957
2022
Q1
$6.41M Sell
77,319
-50,969
-40% -$4.22M 0.05% 547
2021
Q4
$9.63M Buy
128,288
+91,960
+253% +$6.9M 0.09% 263
2021
Q3
$4.22M Buy
36,328
+21,354
+143% +$2.48M 0.05% 544
2021
Q2
$3.32M Sell
14,974
-65,846
-81% -$14.6M 0.04% 770
2021
Q1
$10.7M Buy
80,820
+23,631
+41% +$3.12M 0.14% 143
2020
Q4
$9.9M Buy
57,189
+27,717
+94% +$4.8M 0.14% 164
2020
Q3
$3.28M Sell
29,472
-193,966
-87% -$21.6M 0.05% 612
2020
Q2
$13.3M Buy
223,438
+199,621
+838% +$11.8M 0.23% 70
2020
Q1
$1.6M Sell
23,817
-14,892
-38% -$1M 0.04% 570
2019
Q4
$3.26M Buy
38,709
+13,844
+56% +$1.17M 0.06% 480
2019
Q3
$1.86M Sell
24,865
-18,562
-43% -$1.39M 0.04% 658
2019
Q2
$2.75M Sell
43,427
-19,611
-31% -$1.24M 0.05% 538
2019
Q1
$3.04M Buy
+63,038
New +$3.04M 0.1% 284
2018
Q4
Sell
-4,379
Closed -$229K 2201
2018
Q3
$229K Buy
+4,379
New +$229K 0.01% 1322
2016
Q1
Sell
-13,115
Closed -$293K 1764
2015
Q4
$293K Buy
+13,115
New +$293K 0.02% 1129